Global Non-melanoma Skin Cancer Market 2014-2018 - Market Trends, Size, Analysis & Forecast

1
Global Non-melanoma Skin Cancer Market 2014-2018
Market , Share, Size, Trends, Analysis, Demand
Forecast to 2018
2
Report Description
About Non-melanoma Skin Cancer Non-melanoma skin
cancer is one of the most common types of cancer
in the world. It develops in the upper layers of
the skin, but not in melanocytes. There are two
types of non-melanoma skin cancer BCC, which
starts in the basal cells, and SCC, which starts
in the squamous cells. BCC usually develops in
the areas such as the head and neck, whereas SCC
starts in the face, ears, neck, lips, and backs
of the hands. These can also grow in wounds or
chronic skin sores. Non-melanoma skin cancer is
caused by unprotected and excessive exposure to
UV radiation. It affects men more than women. It
can be cured effectively if it is detected early.
Treatment for non-melanoma skin cancer includes
surgery, laser therapy, cryotherapy, creams,
radiotherapy, chemotherapy, and PDT.   The Global
Non-melanoma Skin Cancer market to grow at a CAGR
of 27.93 percent over the period
2013-2018.   Read more details at
http//www.bigmarketresearch.com/global-non-melano
ma-skin-cancer-2014-2018-market
3
Report Description
Covered in this Report This report covers the
present scenario and the growth prospects of the
Global Non-melanoma Skin Cancer market for the
period 2014-2018. To calculate the market size,
the report considers the revenue generated from
the following segments Chemotherapy, which
includes drugs used in the treatment of SCC, BCC,
and actinic keratosis Non-invasive Treatments,
which include PDT, radiotherapy, cryotherapy, and
laser therapy   The Global Non-melanoma Skin
Cancer Market 2014-2018, has been prepared based
on an in-depth market analysis with inputs from
industry experts. The report covers the Americas
and, the EMEA and the APAC region and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market.   Key Vendors Elekta
AB F. Hoffmann-la Roche Ltd. iCAD Inc. Meda
AB Valeant Pharmaceuticals Inc. Varian
Medical Systems Inc.
4
Key Regions
Other Prominent Vendors Aqua Pharmaceuticals
LLC Almirall SA Biofrontera AG Boehringer
Ingelheim GmbH Bristol Myers Squibb Co.
Cannabis Science Inc. Cellceutix Corp. Eli
Lilly and Co. Galderma SA GENEXTRA SpA IRX
Therapeutics Inc. LEO Pharma A/S Merck Co.
Inc. Moberg Pharma AB
5
Key Regions
Market Driver Increasing Incidence of
Non-melanoma Skin Cancer For a full, detailed
list, view our report.   Market Challenge
Availability of Alternative Treatments For a
full, detailed list, view our report.   Market
Trend Emergence of Combination Therapies For
a full, detailed list, view our report.
6
Key Regions
Key Questions Answered in this Report What will
the market size be in 2018 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? About report
http//www.bigmarketresearch.com/report-enquiry/17
944
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-non-melano
ma-skin-cancer-2014-2018-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States